VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6500
-0.0149 (-2.24%)
Jun 12, 2026, 1:53 PM EDT - Market open
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $21.66 million as of June 12, 2026. Its market cap has increased by 34.69% in one year.
Market Cap
21.66M
Enterprise Value
-2.77M
1-Year Change
34.69%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $21.66M, a decrease of -90.57%. That is a compound annual growth rate of -31.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 21.66M | 12.17% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 24.53M |
| Pluri | 24.38M |
| Longeveron | 23.99M |
| Neuphoria Therapeutics | 23.89M |
| Marker Therapeutics | 23.84M |
| Allarity Therapeutics | 23.04M |
| Celularity | 22.39M |
| Vistagen Therapeutics | 21.20M |